Atlas Trials

Cyclosporine For The Treatment Of COVID-19(+)

Clinical trial NCT04492891 · COMPLETED

Trial details

NCT number
NCT04492891
Sponsor
Bryan Burt, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SARS (Disease)
Start date
2020-11-23
Primary completion
2021-12-10
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.